Study of TU7710 in Warfarin Anti-coagulated Healthy Male Subjects
Status:
COMPLETED
Trial end date:
2024-08-21
Target enrollment:
Participant gender:
Summary
This is a Phase 1a, double-blind, randomized, placebo- controlled, SAD study to assess safety, tolerability, PK, and PD of TU7710 in warfarin treated healthy male participants.